Saher Hamed

SEBANA Medical is developing a simple and affordable solution to decrease fat cell resorption after autologous fat tissue transplantation for soft tissue augmentation using erythropoietin (EPO). Incorporating EPO molecules into fat tissue after its liposuction and before the fat tissue is re-injected into the body is a safe and simple method that significantly delays the resorption of the injected autologous fat into the surrounding tissue. SEBANA Medicals unique technology is suitable for breast augmentation, body sculpting and the filling of facial wrinkles. The company had a pending patent for the aesthetic use of EPO for this purpose.